Toggle navigation image image
Toggle navigation logologo
image image
  • About Inflarx
    • Leadership Team
    • Board
    • Company History
    • Vision
  • R&D
    • About Complement
    • About C5A
    • Technology
    • Pipeline
    • Clinical Development
      • Hidradenitis Suppurativa
        • Shine Study FAQ
      • ANCA-Associated Vasculitis
      • Pyoderma Gangraenosum
      • COVID-19
      • cSCC
    • Clinical Trials
    • Publications & Posters
  • Investors
    • Press Releases
    • Events & Presentations
    • Financial Information
    • Share Information
    • Analyst Coverage
    • Corporate Governance
    • Annual/Extraordinary General Meetings
    • E-mail alerts
  • Career
    • Open Positions
      • Office Manager (m/w/d)
      • Controller (m/w/d)

American Heart Association Scientific Sessions 2022, Chicago, IL, USA

  • Home
  • Investors
  • Events & Presentations
  • American Heart Association Scientific Sessions 2022, Chicago, IL, USA

InflaRx Presentation:

Speaker:

Djillali Annane, MD, Hôpital Raymond-Poincare – Univ Paris Saclay-UVSQ, Garches, France

Date:

Monday, November 7, 2022

Time:

8:00 to 8:10 am CT US

Presentation:

​​​​​​​"Anti-c5a Vilobelimab Reduces All-cause Mortality in Critically Ill Covid-19 Patients and in Those with Comorbid Hypertension: A Phase 3 Randomized Double-blind, Placebo-controlled Study"

<< back to list

Quick Links
  • Impressum
  • Privacy
  • Technology
  • News
  • Career
  • Disclaimer
  • Contact
  • Newsletter
  • Member area
Contact Jena

InflaRx N.V. / InflaRx GmbH
Winzerlaer Str. 2
07745 Jena

+49 3641 508 180

info@inflarx.de

InflaRx on Linkedin

Contact Munich

InflaRx N.V. / InflaRx GmbH
Fraunhoferstraße 22
82152 Martinsried

+49 89 414 189 78 00

info@inflarx.de

Contact Ann Arbor

InflaRx Pharmaceuticals Inc.
600 S. Wagner Rd.
Ann Arbor, MI 48103

info@inflarx.de

© Copyright 2017 All Rights Reserved.
  • Developed by Ementals